Photocure Raises 2026 Growth Outlook as US Accounts Climb 20%
OSLO – – October 29, 2026 -- Photocure ASA raised its 2026 product revenue growth guidance to 10% to 12% on a constant currency basis, up from 8% to 11%, after Hexvix/Cysview revenues of NOK 134.2 million in the third quarter matched the prior-year level of NOK 134.1 million.
Reported earnings fall despite flat core sales
Adjusted EBITDA came in at NOK 18.5 million, against NOK 18.9 million in Q3 2025. Total revenues rose to NOK 140.9 million from NOK 135.0 million. Reported EBITDA dropped to NOK 4.0 million from NOK 10.2 million, and EBIT swung to NOK -3.4 million from NOK 2.9 million. Cash and cash equivalents stood at NOK 162.4 million at quarter-end.
The company also expects continued expansion of its adjusted EBITDA margin in 2026.